TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Ten-Year Breast Cancer Survival Improved In Past 60 Years, MD Anderson Study Finds October 29, 2010
TCL Archive Also in this 8-page issue: FDA begins search for director of new Office of Oncology Drug Products. October 8, 2004
